Stay updated on Modakafusp Alfa + Daratumumab in MM Clinical Trial
Sign up to get notified when there's something new on the Modakafusp Alfa + Daratumumab in MM Clinical Trial page.

Latest updates to the Modakafusp Alfa + Daratumumab in MM Clinical Trial page
- Check3 days agoChange DetectedNew history entries on 2025-12-03 and 2025-12-19 add More Information, Contacts/Locations, and Study Status, with Revision: v3.3.3. The HHS Vulnerability Disclosure entry was removed on 2025-08-06 (Revision: v3.3.2).SummaryDifference0.7%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page history shows a new revision entry (v3.3.2) and removal of v3.3.1, a routine maintenance log rather than substantive content change. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check31 days agoChange DetectedA new revision entry, v3.3.1, has been added to the page history.SummaryDifference0.1%

- Check38 days agoChange DetectedThe government funding/operating status notice banner on the page has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check53 days agoChange DetectedRecent versions update the study's status (Study Status/Recruitment Status) in the history. These changes reflect ongoing progress and current recruitment status.SummaryDifference0.1%

- Check81 days agoChange DetectedUpgrade to v3.2.0 with a prominent operating-status notice and links; v3.1.0 is removed.SummaryDifference10%

Stay in the know with updates to Modakafusp Alfa + Daratumumab in MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Modakafusp Alfa + Daratumumab in MM Clinical Trial page.